44,392 Shares in Eastman Chemical Company $EMN Bought by Core Capital Management & Research inc.

Key Points

• Core Capital Management & Research acquired 44,392 Eastman Chemical shares worth approximately $3.28 million, making EMN 1.7% of its portfolio. Institutional investors collectively own 83.65% of the company.
• Eastman Chemical exceeded quarterly earnings expectations, reporting $1.97 EPS versus the $1.82 consensus and $2.51 billion in revenue, up 9.9% year over year. The company also declared a quarterly dividend of $0.84 per share, representing a 4.9% annualized yield.
• Analysts maintain a “Moderate Buy” consensus, with seven Buy and seven Hold ratings and an average price target of $79.17, compared with the stock’s reported opening price of $68.36.

Core Capital Management & Research inc. bought a new stake in shares of Eastman Chemical Company (NYSE:EMN - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 44,392 shares of the basic materials company's stock, valued at approximately $3,281,000. Eastman Chemical makes up 1.7% of Core Capital Management & Research inc.'s investment portfolio, making the stock its 21st largest holding.

A number of other hedge funds and other institutional investors have also bought and sold shares of EMN. Brighton Jones LLC purchased a new position in shares of Eastman Chemical during the 4th quarter valued at about $202,000. Integrated Wealth Concepts LLC increased its holdings in Eastman Chemical by 185.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 6,686 shares of the basic materials company's stock worth $589,000 after acquiring an additional 4,345 shares in the last quarter. Millennium Management LLC raised its stake in Eastman Chemical by 69.2% during the 1st quarter. Millennium Management LLC now owns 194,052 shares of the basic materials company's stock worth $17,098,000 after acquiring an additional 79,376 shares during the period. NewEdge Advisors LLC lifted its holdings in Eastman Chemical by 2.6% during the first quarter. NewEdge Advisors LLC now owns 7,310 shares of the basic materials company's stock valued at $644,000 after purchasing an additional 183 shares in the last quarter. Finally, United Services Automobile Association bought a new position in shares of Eastman Chemical in the first quarter worth approximately $252,000. Hedge funds and other institutional investors own 83.65% of the company's stock.

Eastman Chemical Price Performance

Shares of Eastman Chemical stock opened at $68.36 on Thursday. The firm has a market cap of $7.82 billion, a PE ratio of 17.80, a PEG ratio of 0.86 and a beta of 1.07. The stock has a 50 day moving average of $70.77 and a 200 day moving average of $72.00. The company has a current ratio of 1.50, a quick ratio of 0.76 and a debt-to-equity ratio of 0.72. Eastman Chemical Company has a 12 month low of $56.11 and a 12 month high of $83.47.

Eastman Chemical (NYSE:EMN - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.82 by $0.15. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.40 billion. Eastman Chemical had a return on equity of 9.46% and a net margin of 4.99%.The company's revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.60 EPS. Eastman Chemical has set its Q3 2026 guidance at 1.970-1.970 EPS. On average, research analysts expect that Eastman Chemical Company will post 6.5 EPS for the current fiscal year.

Eastman Chemical Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $3.36 dividend on an annualized basis and a yield of 4.9%. Eastman Chemical's dividend payout ratio is presently 87.50%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on EMN. The Goldman Sachs Group reissued a "neutral" rating and issued a $75.00 price objective on shares of Eastman Chemical in a research note on Thursday, July 16th. Royal Bank Of Canada upped their target price on shares of Eastman Chemical from $69.00 to $74.00 and gave the stock a "sector perform" rating in a report on Wednesday, August 5th. Citigroup cut their price target on Eastman Chemical from $85.00 to $81.00 and set a "buy" rating for the company in a research note on Monday, August 3rd. Morgan Stanley decreased their price target on Eastman Chemical from $83.00 to $79.00 and set an "overweight" rating on the stock in a report on Thursday, July 2nd. Finally, UBS Group upped their price objective on Eastman Chemical from $89.00 to $92.00 and gave the stock a "buy" rating in a research note on Monday, August 3rd. Seven analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $79.17.

Eastman Chemical Company Profile

Eastman Chemical Company NYSE: EMN is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company's main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.